Familial<unk>  is associated with multiple endocrine neoplasias, VHL and neurofibromatosis1 and should be screened by plasma fractionated metanephrines levels. The next step is to obtain 24-hour urinary fractionated metanephrine levels. Imaging should be considered if the initial tests are positive. Genetic testing also should be performed in high-risk patients.
Pheochromocytoma screening
Hyperaldosteronism screening
Angiomyolipoma screening
Temporal arteritis screening
Metanephric adenoma screening
Papillary thyroid cancer screening
Medullary thyroid cancer screening
Follicular thyroid cancer screening